Table 1.
Descriptive characteristics of patients and controls.
| Variable | TD group (n = 35) | NTD group (n = 35) | HC group (n = 34) | χ2/F value | p value |
|---|---|---|---|---|---|
| Male/Female | 20/15 | 20/15 | 19/15 | 0.0148 | 0.993 |
| Age (year) | 45.1 ± 12.2 | 44.7 ± 11.2 | 44.4 ± 11.6 | 0.02 | 0.983 |
| DLGAP2 Site 1 | 91.9 ± 2.6 | 91.9 ± 2.0 | 90.4 ± 7.0 | 1.29 | 0.280 |
| DLGAP2 Site 2 | 74.7 ± 4.6 | 73.4 ± 5.0 | 70.8 ± 8.4 | 3.61 | 0.0307 |
| DLGAP2 Site 3 | 94.2 ± 1.3 | 94.3 ± 1.1 | 93.4 ± 4.0 | 1.81 | 0.169 |
| DLGAP2 Average | 86.9 ± 1.6 | 86.5 ± 1.8 | 84.9 ± 6.0 | 3.16 | 0.0465 |
Abbreviations: TD = schizophrenia patients with tardive dyskinesia (TD), NTD = schizophrenia patients without TD, HC = healthy controls, χ2 value is based on the chi-square test, F value is based on the generalized linear model.